10. September 2014 | TUBERCULOSIS

Open letter to Janssen on reducing the price of bedaquiline

MSF joins civil society and many other groups in asking Janssen to reduce the price of their new TB medicine, bedaquiline, which is the first new TB drug to receive approval in 40 years.

Read the letter here